Print
Email
Print Edition StoriesTuesday, July 7, 2009
5AM Ventures raises $159M life sciences fund
By Mass High Tech staff
MHT's Galen Moore: Hiring trends and opportunities
MHT's Efrain Viscarolasaga: Tech companies may have to wait for stimulus funds
MHT's Marc Songini: Researchers focus on macular degeneration
Life sciences-focused venture capital firm 5AM Ventures has raised $159 million from 34 investors in its third fund, according to a filing with the U.S. Securities and Exchange Commission.
The seed money provider, which has offices in Waltham and Menlo Park, Calif., had listed almost $120 million in an April filing, according to a report from PE Hub. Its first fund, upon launching in 2004, was valued at $65 million, while its 2006 second fund brought in $150 million.
The 5AM Ventures website lists its managing partners as John Diekman, Scott Rocklage and Andrew Schwab. Among its investments, 5AM Ventures has backed Lexington-based biotech Pulmatrix Inc.; Cambridge-based Semprus BioSciences Corp., an antibacterial coatings biomedical company; and California firms Relypsa Inc., Pearl Therapeutics and Ambrx Inc.
Comments
If you are commenting using a Facebook account, your profile information may be displayed with your comment depending on your privacy settings. By leaving the 'Post to Facebook' box selected, your comment will be published to your Facebook profile in addition to the space below.
RSS Feeds
